Featured News
504NewsBybit Reports Surge in Trading Volume Amidst USDC Volatility
Bybit’s spot market volume for USDC grows by 1,437% Bybit becomes No.2 crypto exchange in MENA DUBAI, UNITED ARAB EMIRATES – Media...
- 878News
Bupa and Quality Healthcare Medical Services Sponsor Cathay/HSBC Hong Kong Sevens 2023
Bupa rolls out a “Healthy Cities Pop-up Truck” with a gigantic rugby ball, immersive digital games, and a free AI health check,...
- 502News
Adaptovate Listed in Financial Times and Statista High Growth Companies Asia-Pacific list for 2023
Building on their Fast-100 listing in Australian Financial Review 2022 SINGAPORE – Media OutReach – 17 March 2023 – On March 15th...
- 677Wire Stories
Dongying embraces bustling digital economy
DONGYING, China–(BUSINESS WIRE)–Dongying city in East China’s Shandong province is speeding up efforts to harness its digital economy to boost the city’s...
- 671Wire Stories
Dongying embraces bustling digital economy
DONGYING, China–(BUSINESS WIRE)–Dongying city in East China’s Shandong province is speeding up efforts to harness its digital economy to boost the city’s...
- 680News
Glass Egg – a Virtuos Studio announces expansion into Dalat, Vietnam
Virtuos is set to become the largest game development company in Vietnam as Glass Egg aims to grow its Dalat team to...
- 611News
Asian Industrial Online Exhibition 2023 Grand Opening
TAIPEI, TAIWAN – Media OutReach – 17 March 2023 – Asian Industrial Online Exhibition (AIOE 2023) is a virtual and physical integration...
- 599News
OASYX Unveils New Range of Virtua Fighter NFTs
The new range of Virtua Fighter NFTs will be overseen and developed by franchise creator, Yu Suzuki SINGAPORE – Media OutReach –...
- 732Wire Stories
Rocket Lab Successfully Launches 34th Electron Rocket, Second Mission from Virginia
LONG BEACH, Calif.–(BUSINESS WIRE)–$RKLB–Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a leading launch and space systems company, today...
- 522Wire Stories
Long-Term Data from CANbridge Pharmaceuticals CAN008 Phase 1/2 Trial in Glioblastoma Multiforme Shows 67% Five-Year Overall Survival Rate Compared to 8.2% in Institutional Database
Data to be Presented at the ESMO Sarcoma and Rare Cancers Annual Congress 83% overall survival at two years vs. 34.3% OS...
- 527Wire Stories
South Korea’s Digital Economy Now Covered by Similarweb
In addition to viewing global online activity, companies seeking insights on digital market share can now filter for activity from within the...
